Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts

Pediatric Infectious Disease Journal

Volumn 28, Issue 10, 2009, Pages 895-899

  Stone, Anne ^a   Quittell, Lynne ^a   Zhou, Juyan ^b   Alba, Luis ^b   Bhat, Meera ^c   Decelie Germana, Joan ^d   Rajan, Sujatha ^d   Bonitz, Lynn ^d   Welter, John J ^e   Dozor, Allen J ^e   Gherson, Ingrid ^e   Lowy, Franklin D ^c,d   Saiman, Lisa ^b,f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Schneider Children's Hospital ^*  (United States)

^d SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Adolescent; Infection; Molecular; Respiratory tract; Transmission

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; EPIDEMIOLOGICAL DATA; FEMALE; GENE CASSETTE; HOUSEHOLD; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; NOSE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY SYSTEM; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROAT CULTURE;

EID: 70349706252     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a3ad0a     Document Type: Article

References (46)

1. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24(suppl 5):S6-S52. (Pubitemid 36617275)
2. Cystic Fibrosis Foundation. Patient Registry 2001 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation.
3. Cystic Fibrosis Foundation. Patient Registry 2006 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-598.
5. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillinresistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis. 1999;29:797-800.
6. Centers for Disease Control and Prevention. Four pediatric deaths from community- acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. Morb Mortal Wkly Rep. 1999;48:707-710.
7. Saiman L, O'Keefe M, Graham PL III, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis. 2003;37:1313-1319.
8. Vandenesch F, Naimi T, Enright M, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-984.
9. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352: 1436-1444.
10. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-674.
11. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298: 1763-1771.
12. Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44:108-118.
13. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505-520.
14. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344: 11-16. (Pubitemid 32064839)
15. Graham PL III, Morel AS, Zhou J, et al. Epidemiology of methicillinsusceptible Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2002;23:677-682.
16. Haas JP, Evans AM, Preston KE, et al. Risk factors for surgical site infection after cardiac surgery: the role of endogenous flora. Heart Lung. 2005;34:108-114.
17. Pan ES, Diep BA, Charlebois ED, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus and their relation to community-associated disease activity. J Infect Dis. 2005;192:811-818.
18. Goerke C, Kraning K, Stern M, et al. Molecular epidemiology of community- acquired Staphylococcus aureus in families with and without cystic fibrosis patients. J Infect Dis. 2000;181:984-989.
19. Ridder-Schaphorn S, Ratjen F, Dubbers A, et al. Nasal Staphylococcus aureus carriage is not a risk factor for lower airway infection in young cystic fibrosis patients. J Clin Microbiol. 2007;45:2979-2984.
20. Tramper-Stranders GA, van der Ent CK, Gerritsen SA, et al. Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts? J Antimicrob Chemother. 2007;60:665-668.
21. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910-917.
22. Huijsdens XW, van Santen-Verheuvel MG, Spalburg E, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2006;44:2994-2996.
23. Jones TF, Creech CB, Erwin P, et al. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006;42:e76-e78.
24. Zhou J, Garber E, Desai M, et al. Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol. 2006;44:1547-1549.
25. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46: 2155-2161.
26. Cespedes C, Miller M, Quagliarello B, et al. Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol. 2002;40:2594-2597.
27. Campana S, Cocchi P, Doring G, et al. Emergence of an epidemic clone of community-associated methicillin-resistant Panton-Valentine Leukocidinnegative Staphylococcus aureus in Cystic Fibrosis Patient Populations. J Clin Microbio. 2007;3146-3147.
28. Elizur A, Orscheln RC, Ferkol TW, et al. Panton Valentine leukocidinpositive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007;131:1718-1725.
29. Vergison A, Denis O, Deplano A, et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother. 2007;59:893-899.
30. Glikman D, Siegel JD, David MZ, et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from children with cystic fibrosis in the era of epidemic community-associated MRSA. Chest. 2008;133:1381-1387.
31. Molina A, Del Campo R, Maiz L, et al. High prevalence in cystic fibrosis patients of multi-resistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother. 2008;62:961-967.
32. Hussain FM, Boyle-Vavra S, Daum RS. Community-acquired methicillinresistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatr Infect Dis J. 2001;20:763-767.
33. Nakamura MM, Rohling KL, Shashaty M, et al. Prevalence of methicillinresistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J. 2002;21:917-922.
34. Creech CB II, Kernodle DS, Alsentzer A, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24:617-621.
35. Graham PL III, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006;144:318-325.
36. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193:172-179.
37. Fritz SA, Garbutt J, Elward A, et al. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics. 2008;121:1090-1098.
38. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002;34:425-433.
39. Lowy FD, Aiello AE, Bhat M, et al. Staphylococcus aureus colonization and infection in New York State prisons. J Infect Dis. 2007;196:911-918.
40. Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:752-760.
41. Miall LS, McGinley NT, Brownlee KG, et al. Methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Arch Dis Child. 2001;84:160-162.
42. Ren CL, Morgan WJ, Konstan MW, et al. Presence of methicillin-resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42:513-518.
43. Dasenbrook EC, Merlo CA, Diener-West M, et al. Persistent methicillinresistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008;178:814-821.
44. Sawicki G, Rasouliyan L, Pasta DJ, et al. The impact of incident methicillin- resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol. 2008;43:1117-1123.
45. Taccetti G, Neri AS, Festini F, et al. Methicillin-resistant Staphylococcus aureus in cystic fibrosis. Pediatr Pulmonol. 2008;43:309.
46. Nadesalingam K, Conway SP, Denton M. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. J Cyst Fibros. 2005;4:49-52.